Feed Top Reports Pricing

⌘K

17:04:20·23d

SECFiling

SEC Form 10-K filed by Femasys Inc.

FEMY· Femasys Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

FEMY
Femasys Inc.
Health Care

Recent analyst ratings

Nov 20UpdateLaidlaw$6.50
Jul 13UpdateJonesTrading$18.00
Jul 13UpdateChardan Capital$25.00

Related

PR1d
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
PR7d
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
SEC17d
SEC Form DEF 14A filed by Femasys Inc.
INSIDER22d
SEC Form 4 filed by Canning John Charles
INSIDER22d
SEC Form 3 filed by new insider Canning John Charles
SEC22d
Femasys Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
PR22d
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
SEC23d
SEC Form S-8 filed by Femasys Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022